Selecta Biosciences
SELB
$0.88
Share price
-8.00%
Change (1 day)
-36.60%
Change (1 year)
Categories
Selecta Biosciences (SELB) - Cash on Hand
Cash on Hand as of September 2023 : $79.6 M
According to Selecta Biosciences's latest financial reports the company has $79.6 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Selecta Biosciences - Cash on Hand chart (from 2015 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.13 B | 5.11% |
| 2021-12-31 | $0.12 B | -7.66% |
| 2020-12-31 | $0.13 B | 54.28% |
| 2019-12-31 | $89.89 M | 140.34% |
| 2018-12-31 | $37.4 M | -61.27% |
| 2017-12-31 | $96.56 M | 14.76% |
| 2016-12-31 | $84.14 M | 130.76% |
| 2015-12-31 | $36.46 M | 119.76% |
| 2014-12-31 | $16.59 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 161.53% | 🇺🇸 USA |